MIRANDA TURNER: Open Payments
NPI 1225794928 · MULLICA HILL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 34 payments from 11 companies in 2025. Trend: 2023 $886 · 2024 $512 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $225 |
| ABBVIE INC. | 11 | $158 |
| SHIELD THERAPEUTICS INC | 2 | $61 |
| Exact Sciences Corporation | 2 | $57 |
| Novo Nordisk Inc | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Boston Scientific Corporation | 1 | $41 |
| ANI Pharmaceuticals, Inc. | 2 | $39 |
| InSightec,Inc | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
Products named: FANAPT, VRAYLAR, ACCRUFER, Cologuard Collection Kit, Wegovy, FARXIGA, QULIPTA, General - DBS.
Industry payments across NJ — which companies pay providers there.
